Welcome to the newest edition of the HIV Vaccine Trials Network (HVTN) Community Compass.
In this issue, we showcase some of the amazing and committed members of our family who work hard to support community engagement, administrative operations, and clinical trial operations. We also introduce a groundbreaking new phase 3 HIV vaccine study that will test a candidate HIV vaccine regimen in several countries on multiple continents around the world.
Please help us ensure that this publication is representative of our entire global HVTN community! HVTN members (who have access to the HVTN member's website) can use our submission page that offers the ability to submit content and articles for inclusion in future issues.
Thank you for your continued support of the HVTN wherever you are in the world, for the work that you do in whatever role you have in the HVTN community, and for the impact we have been able to make in our collective history and communities, together. Though we have come very far in response to the HIV epidemic, we have so much further to go to achieve an effective global HIV vaccine. The HVTN Community Compass team wants to be everywhere you are, so please share with us what's happening at your research sites, institutions, and in your communities, so that we can share it with the world.
Stephaun E. Wallace, PhD
Editor-in-Chief, HVTN Community Compass